Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Product Revenue $ 612,123 $ 302,475
Product Cost of Sales (245,937) (297,500)
Gross Income 366,186 4,975
Administrative Expenses 982,953 915,533
Sales and Marketing Expenses 149,841 500,152
Compliance, Research and Development Expenses 88,391 439,970
Litigation Settlement Expenses 75,000
Amortization of Non-Current Assets 10,003 42,777
Loss from Operations (940,002) (1,893,457)
Other (Income)/Expenses    
Foreign Currency Transaction Loss 4,659 2,875
Loss on Investments 3,718
Interest and Dividend Income (31,421) (36,341)
Total Other Income (23,044) (33,466)
Loss Before Income Taxes (916,958) (1,859,991)
Income Tax Benefit
Net Loss (916,958) (1,859,991)
Other Comprehensive Gain/(Loss)    
Net Unrealized Gain/(Loss) on Marketable Securities 29,343 (16,843)
Total Other Comprehensive Gain/(Loss) 29,343 (16,843)
Comprehensive Income (Loss) $ (887,615) $ (1,876,834)
Basic and Diluted loss per common share $ (0.07) $ (0.21)
Weighted average basic and diluted common shares outstanding 12,483,209 8,956,279